HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2008.111963v1 55/3/505    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thuerlemann, C. Articles by Alberio, L. Search for Related Content PubMed PubMed Citation Articles by Thuerlemann, C. Articles by Alberio, L.

Monitoring Thrombin Generation by Electrochemistry: Development of an Amperometric Biosensor Screening Test for Plasma and Whole Blood

¹ Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital and University of Bern, Switzerland; ² Department of Clinical Research, University of Bern, Switzerland.

^aAddress correspondence to these authors at: Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital and University of Bern, CH-3010 Bern, Switzerland. Fax 0041 31 632 34 06; e-mails charles.thuerlemann{at}bluewin.ch, lorenzo.alberio{at}insel.ch.

Background: Complete investigation of thrombophilic or hemorrhagic clinical presentations is a time-, apparatus-, and cost-intensive process. Sensitive screening tests for characterizing the overall function of the hemostatic system, or defined parts of it, would be very useful. For this purpose, we are developing an electrochemical biosensor system that allows measurement of thrombin generation in whole blood as well as in plasma.

Methods: The measuring system consists of a single-use electrochemical sensor in the shape of a strip and a measuring unit connected to a personal computer, recording the electrical signal. Blood is added to a specific reagent mixture immobilized in dry form on the strip, including a coagulation activator (e.g., tissue factor or silica) and an electrogenic substrate specific to thrombin.

Results: Increasing thrombin concentrations gave standard curves with progressively increasing maximal current and decreasing time to reach the peak. Because the measurement was unaffected by color or turbidity, any type of blood sample could be analyzed: platelet-poor plasma, platelet-rich plasma, and whole blood. The test strips with the predried reagents were stable when stored for several months before testing. Analysis of the combined results obtained with different activators allowed discrimination between defects of the extrinsic, intrinsic, and common coagulation pathways. Activated protein C (APC) predried on the strips allowed identification of APC-resistance in plasma and whole blood samples.

Conclusions: The biosensor system provides a new method for assessing thrombin generation in plasma or whole blood samples as small as 10 µL. The assay is easy to use, thus allowing it to be performed in a point-of-care setting.

The following articles in journals at HighWire Press have cited this article:

				T. K. Brock, N. L. Gentile, R. F. Louie, N. K. Tran, T. Kitano, and G. J. Kost Assessing Thrombin Generation at the Point of Care Clin. Chem., March 1, 2009; 55(3): 398 - 399. [Full Text] [PDF]